Skip to main content
. Author manuscript; available in PMC: 2018 Jan 9.
Published in final edited form as: Clin Infect Dis. 2015 Mar 16;61(2):157–168. doi: 10.1093/cid/civ220

Figure 1.

Figure 1

Estimated incremental change in per person costs and per person quality-adjusted life-years estimated across 9 published scenarios that tested population hepatitis C virus testing followed by treatment. Abbreviations: PR, pegylated interferon and ribavirin; QALY, quality-adjusted life-year.